Safety and Efficacy of Cellular Drugs, Objective Response Rate of Subjects, Etc
1 clinical trials · Condition
◉ Watch Safety and Efficacy of Cellular Drugs, Objective Response Rate of Subjects, Etc
| Record | Firm | Date |
|---|---|---|
| Clinical Study on the Safety and Efficacy of CAR-T/CAR-NK Cells in the Treatment of Recurrent Refractory or Unresectable Solid Tumors (NCT06572956) | The Second Hospital of Shandong University | 2024-03-21 |
Track Safety and Efficacy of Cellular Drugs, Objective Response Rate of Subjects, Etc automatically
Every clearance here is in the API, with alerts when new ones post.